Skip to content

Prasugrel

Effient, Efient (prasugrel) is a small molecule pharmaceutical. Prasugrel was first approved as Effient on 2009-02-24. It has been approved in Europe to treat acute coronary syndrome, myocardial infarction, and unstable angina.
Trade Name Efient
Common Name Prasugrel
Indication acute coronary syndrome, myocardial infarction, unstable angina
Drug Class Platelet aggregation inhibitors
Prasugrel
Get full access now